Zanidatamab Zovodotin
February 22, 2023 - February 23, 2023

Design and Functional Characterization of Zanidatamab Zovodotin (ZW49), a HER2-targeting Biparatopic Antibody Drug Conjugate in Clinical Development​

Stuart Barnscher